13F HOLDINGS REPORT
ENAVATE SCIENCES GP, LLC
Quarter ended Q4 2024 · Filed February 14, 2025 · Accession 0001104659-25-014094
Total Value
$139.2M
Positions
5
Other Managers
0
Confidential Omitted
No
Holdings (5)
| # | Issuer | Ticker / CUSIP | Shares | Value | % of Filing |
|---|---|---|---|---|---|
| 1 | UPSTREAM BIO INC | UPB | 2,459,703 | $40.4M | 29.04% |
| 2 | IMMUNOME INC | IMNM | 3,478,261 | $36.9M | 26.53% |
| 3 | ZENAS BIOPHARMA INC | ZBIO | 3,761,359 | $30.8M | 22.12% |
| 4 | CAMP4 THERAPEUTICS CORP | CAMP | 3,785,802 | $19.8M | 14.19% |
| 5 | COMPASS THERAPEUTICS INC | CMPX | 7,788,150 | $11.3M | 8.11% |